Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Huynh

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Biochemical Pharmacology|June 29, 2014
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)Leanna Cheung, Claudia L Flemming, Fujiko Watt, et al.
Diabetes Care|January 16, 2026
A Comparison of Diet and Exercise During Pregnancy in Women With and Without Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) StudyRebecca L Thomson, Guinevere Martin, James D Brown, et al.
Diabetologia|September 2, 2024
Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) studyRebecca L Thomson, James D Brown, Helena Oakey, et al.
Nature Communications|December 3, 2025
Indigenous infants in remote Australia retain an ancestral gut microbiome despite encroaching WesternizationLeonard C Harrison, Theo R Allnutt, Sarah Hanieh, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 12, 2024
Protocol for the Australian Type 1 Diabetes National Screening Pilot: Assessing the feasibility and acceptability of three general population screening models in childrenKirstine J Bell, Shannon Brodie, Jennifer J Couper, et al.
Plos One|May 14, 2013
VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in miceJesse M Damsker, Blythe C Dillingham, Mary C Rose, et al.
Nature Communications|May 29, 2024
Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitisHaressh Sajiir, Sahar Keshvari, Kuan Yau Wong, et al.
EMBO Molecular Medicine|September 10, 2013
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effectsChristopher R Heier, Jesse M Damsker, Qing Yu, et al.
Diabetes Care|January 29, 2025
Islet Autoantibody Screening Throughout Australia Using In-Home Blood Spot Sampling: 2-Year Outcomes of Type1ScreenJohn M Wentworth, Anna B E Sing, Gaetano Naselli, et al.
Diabetologia|December 11, 2025
Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohortJennifer J Couper, Helena Oakey, Megan A S Penno, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Biochemical Pharmacology|June 29, 2014
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)Leanna Cheung, Claudia L Flemming, Fujiko Watt, et al.
Diabetes Care|January 16, 2026
A Comparison of Diet and Exercise During Pregnancy in Women With and Without Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) StudyRebecca L Thomson, Guinevere Martin, James D Brown, et al.
Diabetologia|September 2, 2024
Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) studyRebecca L Thomson, James D Brown, Helena Oakey, et al.
Nature Communications|December 3, 2025
Indigenous infants in remote Australia retain an ancestral gut microbiome despite encroaching WesternizationLeonard C Harrison, Theo R Allnutt, Sarah Hanieh, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 12, 2024
Protocol for the Australian Type 1 Diabetes National Screening Pilot: Assessing the feasibility and acceptability of three general population screening models in childrenKirstine J Bell, Shannon Brodie, Jennifer J Couper, et al.
Plos One|May 14, 2013
VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in miceJesse M Damsker, Blythe C Dillingham, Mary C Rose, et al.
Nature Communications|May 29, 2024
Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitisHaressh Sajiir, Sahar Keshvari, Kuan Yau Wong, et al.
EMBO Molecular Medicine|September 10, 2013
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effectsChristopher R Heier, Jesse M Damsker, Qing Yu, et al.
Diabetes Care|January 29, 2025
Islet Autoantibody Screening Throughout Australia Using In-Home Blood Spot Sampling: 2-Year Outcomes of Type1ScreenJohn M Wentworth, Anna B E Sing, Gaetano Naselli, et al.
Diabetologia|December 11, 2025
Evolution of islet autoantibodies in the Environmental Determinants of Islet Autoimmunity (ENDIA) prospective cohortJennifer J Couper, Helena Oakey, Megan A S Penno, et al.
Pageof 9